Details
Category: Volume 08 Issue 01 January 2020
Hits: 1009

Title: Compare the Level of GPBB in Acute Myocardial Infarction with and Without Diabetes Mellitus Patients

Authors: Chanchal Garg, Dr Neelima Singh, Rakesh Shah, Prerna Vyas Gokhle, Dr Vedika Rathore, Dr Roshan Kumar Mahat

 DOI: https://dx.doi.org/10.18535/jmscr/v8i1.160

Abstract

Diabetes mellitus is associated with high risk factor in patients with acute myocardial infarction. In the myocardial infarction patients Glycogenphophorylse BB is a sensitive and specific marker.The present study was conducted with this objective to find out the status of GPBB in acute myocardial infarction with and without patients.  For this study we included 64 AMI (33 with diabetes mellitus and 31 without diabetes mellitus) and 64 healthy subjects. AMI diagnosed according to the ACC guideline i.e. clinical symptom chest pain, electrocardiograph monitoring and elevated cardiac biomarker. Cardiac marker GPBB was elevated in all the patients within 1 hour after onset of chest pain but it was more elevated in AMI with diabetic patients as compare to the without diabetic patients and there is no statistically significant difference of GPBB between AMI with diabetic and without diabetic patients. We found the highest mean level of GPBB within 3 hour after onset of chest pain.

Keywords: Diabetes mellitus; Acute myocardial infraction; Glycogen phosphorylase BB.

References

  1. Peters SA, Huxley RR, Woodward M. Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events. Diabetologia. 2014; 57:1542–1551.
  2. Idris I. Game F, Jeffcoate W. Does close glycaemic control promote healing in diabetic foot ulcers? Reports of a feasibility study. Diabet Med 2005; 22(8):1060-1063.
  3. Seshasai SR, Kaptoge S, Thompson A, Di Angelantonio E, Gao P, Sarwar N, Whincup PH, Mukamal KJ, Gillum RF, HolmeI, Njlstad I, Fletcher A, Nilsson P, Lewington S, Collins R, Gudnason V,Thompson SG, Sattar N, Selvin E, Hu FB, Danesh J. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011; 364:829–841.
  4. Bartnik M, Ryden L, Ferrari R, et al. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25:1880–1890.
  5. Gore MO, Patel MJ, Kosiborod M, et al. Diabetes mellitus and trends in hospital survival after myocardial infarction, 1994 to 2006: data from the national registry of myocardial infarction. Circ Cardiovasc Qual Outcomes 2012; 5:791–797.
  6. Kasap S, Gonenc A, Sener DE, Hisar I. Serum Cardiac Markers in Patients with Acute Myocardial Infarction: Oxidative Stress, C-reactive protein and N-terminal probrain natriuretic peptide. J Clin Biochem Nutr. 2007; 41: 50-57.
  7. Wahab NN, Cowden EA, Pearce NJ, Gardner MJ, Merry H, Cox JL. Is blood glucose anindependent predictor of mortality in acute myocardial infarction in the thrombolytic era? J Am Coll Cardiol. 2002; 40:1748 –1754.
  8. Alhashemi JA. Diagnostic accuracy of a bedside qualitative immunochromato-graphic test for acute myocardial infarction. Am J Emerg Med. 2006; 24(2):149–155.
  9. Wu AH, Feng YJ, Contois JH, Pervaiz S. Comparison of myoglobin, creatine kinase-MB, and cardiac troponin I for diagnosis of acute myocardial infarction. Ann Clin Lab Sci. 1996; 26(4):291-300.
  10. Nigam PK. Biochemical markers of myocardial injury. Indian J Clin Biochem. 2007; 22(1):10–17.
  11. McQueen MJ, Holder D, El-Maraghi NR. Assessment of the accuracy of serial electrocardiograms in the diagnosis of myocardial infarction. Am Heart J. 1983; 105(2):258-261.
  12. Alpert JS, Thygesen K, Antman E, Bassand JP. Myocardial infarction redefined – a consensus document of The Joint European Society of Cardiology/ American College of Cardiology Committee for the redefinition of myocardial infarction. J Am Coll Cardiol 2000; 36:959–969.
  13. Lippi G, Mattiuzzi C, Comelli I, Cervellin G. Glycogen phosphorylase isoenzyme BB in the diagnosis of acute myocardial infarction: a meta-analysis. Biochem Med (Zagreb). 2013; 23(1):78–82.
  14. Rabitzsch G, Mair J, Leichleitner P, Noll F, Hofmann U, Krause EG. Isoenzyme BB of glycogen phosphorylase b and myocardial infarction. Lancet. 1993; 34:1032-1033.
  15. Rabitzsch G, Mair J, Lechleitner P, Noll F, Hofmann U, Krause EG, et al. Immunoenzymometric assay of human glycogen phosphorylase isoenzyme BB in diagnosis of ischemic myocardial injury. Clin Chem. 1995; 41(7):966-978.
  16. Lacnák B, Stejskal D, Jedelský L, Karpísek M, Sprongl L. Utilization of glycogen phosphorylase BB measurement in the diagnosis of acute coronary syndromes in the event of chest pain. Vnitr Lek. 2007; 53:1164-1169.
  17. Stejskal D, Lacnak B, Jedelsky L, Stepanova L, Proskova J, Solichova P, et al. Use of glycogen phosphorylase BB measurement with POCT in the diagnosis of acute coronary syndromes. A comparison with the ELISA method. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2007; 151(2):247-249.
  18. Rajkakati R, Baruah SM, Timung D.  Dyslipidemia is not the only Risk Factor for AMI in Non-Diabetic Population: A Hospital Based Prospective Observational Study. (IOSR-JDMS.2017; 16(4); 33-36.
  19. Mani VE, John M, Calton R. Impact of HbA1c on Acute Cardiac States. JAPI. 2011; 59(6); 1-3.
  20. Soomro T, Memon AG, Memon S. Frequency of Acute Myocardial Infarction in Patients with Diabetes Mellitus. J Liaquat Uni Med Health Sci. 2016; 15(01):35-39.
  21. Singh N, Rathore V, Mahat RK, Rastogi P.Glycogen Phosphorylase BB: A more Sensitive and Specific Marker than Other Cardiac Markers for Early Diagnosis of Acute Myocardial Infarction. Ind J Clin Biochem; 2018; 33; 356–360.
  22. Peetz D, Post F, Schinzel H, Schweigert R, Schollmayer C, Steinbach K, et al. Glycogen phosphorylase BB in acute coronary syndromes. Clin Chem Lab Med. 2005; 43(12):1351–1358.
  23. Bozkurt S, Kaya EB, Okutucu S, Aytemir K, Coskun F, Oto A. The diagnostic and prognostic value of first hour glycogen phosphorylase isoenzyme BB level in acute coronary syndrome. Cardiol J. 2011; 18(5):496–502.
  24. Cubranic Z, Madzar Z, Matijevic S, Dvornik S, Fisic E, Tomulic V, et al. Diagnostic accuracy of heart fatty acid binding protein (H-FABP) and glycogen phosphorylase isoenzyme BB (GPBB) in diagnosis of acute myocardial infarction in patients with acute coronary syndrome. Biochem Med (Zagreb). 2012; 22(2):225–236.

Corresponding Author

Chanchal Garg

PhD. Scholar, G.R. Medical College, Gwalior (M.P.)